Provided by Tiger Trade Technology Pte. Ltd.

Esperion Therapeutics

3.40
+0.22006.92%
Post-market: 3.400.00000.00%19:22 EST
Volume:4.77M
Turnover:16.15M
Market Cap:812.82M
PE:-6.35
High:3.45
Open:3.25
Low:3.22
Close:3.18
52wk High:4.18
52wk Low:0.6925
Shares:239.06M
Float Shares:237.00M
Volume Ratio:1.23
T/O Rate:2.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5358
EPS(LYR):-0.2764
ROE:97.76%
ROA:-5.42%
PB:-1.80
PE(LYR):-12.30

Loading ...

Esperion (ESPR) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Jan 28

Piper Sandler Sticks to Their Buy Rating for Esperion (ESPR)

TIPRANKS
·
Jan 16

Esperion reports preliminary FY25 revenue $400M-$408M, consensus $393.11M

TIPRANKS
·
Jan 12

BRIEF-Esperion Reports $156 To $160 Million In Preliminary Full-Year 2025 U.S. Net Product Sales

Reuters
·
Jan 12

Esperion Therapeutics Projects 2025 Revenue Up to $408 Million and Operating Expenses Up to $245 Million for 2026

Reuters
·
Jan 12

Esperion Therapeutics Inc - Reports $156 to $160 Mln in Preliminary* Full-Year 2025 U.S. Net Product Sales

THOMSON REUTERS
·
Jan 12

Esperion Provides Business Update at 44TH Annual J.p. Morgan Healthcare Conference

THOMSON REUTERS
·
Jan 12

Esperion Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
Jan 12

BRIEF-Esperion Announces Inducement Grants Under Nasdaq Listing Rule

Reuters
·
Dec 10, 2025

Esperion Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Dec 10, 2025

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Dec 10, 2025

Esperion Therapeutics Shares Rise After Piper Sandler Initiates Coverage

MT Newswires Live
·
Nov 26, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Applied Materials, CDW,  Kohl's

Reuters
·
Nov 25, 2025

Esperion Therapeutics Initiated at Overweight by Piper Sandler

Dow Jones
·
Nov 25, 2025

Piper Sandler Initiates Coverage on Esperion Therapeutics With Overweight Rating

MT Newswires Live
·
Nov 25, 2025

BUZZ-Esperion gains after Piper Sandler initiates with 'overweight' rating

Reuters
·
Nov 25, 2025

Esperion initiated with an Overweight at Piper Sandler

TIPRANKS
·
Nov 25, 2025

U.S. RESEARCH ROUNDUP-Air Products, Hanover Insurance, Kinsale Capital

Reuters
·
Nov 25, 2025

Esperion Therapeutics Inc : Piper Sandler Initiates Coverage With Overweight Rating; Price Target $9

THOMSON REUTERS
·
Nov 25, 2025

BUZZ-U.S. STOCKS ON THE MOVE-IES Holding, Eli Lilly, Alphabet

Reuters
·
Nov 22, 2025